[go: up one dir, main page]

ES2113904T3 - Profarmacos de antraciclinas. - Google Patents

Profarmacos de antraciclinas.

Info

Publication number
ES2113904T3
ES2113904T3 ES92115600T ES92115600T ES2113904T3 ES 2113904 T3 ES2113904 T3 ES 2113904T3 ES 92115600 T ES92115600 T ES 92115600T ES 92115600 T ES92115600 T ES 92115600T ES 2113904 T3 ES2113904 T3 ES 2113904T3
Authority
ES
Spain
Prior art keywords
antibody
enzyme
products
tumor cells
anthraciclin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92115600T
Other languages
English (en)
Inventor
Peter D Senter
Mark G Saulnier
Joseph P Brown
David E Kerr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/211,301 external-priority patent/US4975278A/en
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Priority claimed from EP88112646A external-priority patent/EP0302473B1/en
Application granted granted Critical
Publication of ES2113904T3 publication Critical patent/ES2113904T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6891—Pre-targeting systems involving an antibody for targeting specific cells
    • A61K47/6899—Antibody-Directed Enzyme Prodrug Therapy [ADEPT]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nanotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

ESTA INVENCION SE REFIERE A PROMEDICAMENTOS DE ANTRACICLINA QUE PERMITEN EL SUMINISTRO DE MEDICAMENTOS CITOTOXICOS A LAS CELULAS TUMORALES MEDIANTE LA ADMINISTRACION DE UN CONJUGADO DE ANTICUERPO Y ENZIMA ESPECIFICO PARA LOS TUMORES QUE SE UNE A LAS CELULAS TUMORALES Y LA ADMINISTRACION ADICIONAL DEL PROMEDICAMENTO, QUE ES CONVERTIDO EN EL LUGAR DONDE SE ENCUENTRA EL TUMOR, ANTE LA PRESENCIA DE LA ENZIMA UNIDA AL ANTICUERPO, EN UN MEDICAMENTO CITOTOXICO ACTIVO. LA PRESENTE INVENCION SE REFIERE TAMBIEN A UN METODO PARA LA PREPARACION DE ESTOS PROMEDICAMENTOS. SEGUN UN ASPECTO DE LA INVENCION, SE HA UTILIZADO UN CONGUJADO DE ANTICUERPO Y ENZIMA QUE CONTIENE LA ENZIMA AMIDASA DE LA PENICILINA V ("PVA") JUNTO CON UN NUEVO PROMEDICAMENTO, N AS TUMORALES. LOS PRODUCTOS DE ESTA INVENCION PUEDEN MATAR SELECTIVAMENTE, EN MAYOR MEDIDA, LAS CELULAS TUMORALES Y POR TANTO SON UTILES EN EL TRATAMIENTO DE CANCERES Y DE OTROS TUMORES.
ES92115600T 1987-08-04 1988-08-03 Profarmacos de antraciclinas. Expired - Lifetime ES2113904T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8138287A 1987-08-04 1987-08-04
US16106888A 1988-02-26 1988-02-26
US07/211,301 US4975278A (en) 1988-02-26 1988-06-29 Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells
EP88112646A EP0302473B1 (en) 1987-08-04 1988-08-03 Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells

Publications (1)

Publication Number Publication Date
ES2113904T3 true ES2113904T3 (es) 1998-05-16

Family

ID=27441445

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92115600T Expired - Lifetime ES2113904T3 (es) 1987-08-04 1988-08-03 Profarmacos de antraciclinas.

Country Status (2)

Country Link
ES (1) ES2113904T3 (es)
GR (1) GR3026444T3 (es)

Also Published As

Publication number Publication date
GR3026444T3 (en) 1998-06-30

Similar Documents

Publication Publication Date Title
ES2068191T3 (es) Conjugados anticuerpo-enzima en combinacion con profarmacos para el suministro de agentes citotoxicos a celulas tumorales.
PT693924E (pt) Processos para administracao (in vivo) de substancias biologicas e composicoes utilizadas nestes processos
HUT43948A (en) Emulsion compositions for dosing ionizable hydrophobic medical substances which are little soluble in water and process for preparing the same
PT88985A (pt) Processo para a preparacao de composicoes farmaceuticas nasais e ou oftalmicas contendo azelastina
HK160995A (en) Complex compounds of bioflavonoids with phospholipids their preparation and use and pharmaceutical and cosmetic compositions containing them
RU94038047A (ru) Система подачи лекарств для их одновременной подачи с лекарствами, активизируемыми ферментами и светом
ES2080837T3 (es) Tratamiento de estados y enfermedades.
ES2062700T3 (es) Procedimiento para la preparacion de medicamentos en forma de perlas.
AR008680A1 (es) Substitutos de plaquetas y metodos de conjugacion apropiados para su preparacion
EA199900734A1 (ru) Микрокапсулы, содержащие цис-платину
ES2080549T3 (es) Medicamentos a base de derivados de polihidroximetileno, procedimiento para su preparacion y empleo.
DE69013797D1 (de) Gehirnspezifische Zubereitung mit gesteuerter Abgabe.
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
ES8608313A1 (es) Procedimiento para preparar microcapsulas con liberacion controlada de la substancias activa, que contienen peptidos,reguladores y un material de soporte biologicamente degradable.
ES2113904T3 (es) Profarmacos de antraciclinas.
MX9203405A (es) Compuestos activos para usarse en el tratamiento de tumores.
ES2077559T3 (es) Estabilizacion de proteinas terapeuticamente activas en preparados farmaceuticos.
ES2089667T3 (es) Procedimiento para la preparacion de antibioticos betalactamicos esteriles.
ES2040765T3 (es) Procedimiento para preparar un agente para el tratamiento de enfermedades angiogenas o tumores.
JPS59500272A (ja) 抗ガン剤
AR005724A1 (es) Derivados de ureido biologicamente activos utiles en el tratamiento de esclerosis multiple
PT92071A (pt) Processo de preparacao de imunotoxinas e de preparados farmaceuticos para o tratamento ou profilaxia de doencas auto-imunes
ITMI982634A1 (it) Composizioni farmaceutiche a base di proteine.
ES2037862T3 (es) Aplicacion de grupos nitrofenilos a la estimulacion de las capacidades de incorporacion de un medicamento en las celulas sensibles del huesped.
MY103598A (en) Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 540859

Country of ref document: ES